Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2020 September;45(3) > Minerva Endocrinologica 2020 September;45(3):273-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2020 September;45(3):273-5

DOI: 10.23736/S0391-1977.20.03122-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway

Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 10,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page